approval
saveIMBRUVICA (IBRUTINIB) — FDA approval
community read0 votes
Sponsor: PHARMACYCLICS LLC. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
same company · ±60 days · 6
- approvalIMBRUVICA (IBRUTINIB) — FDA approvalDec 20, 2024
- approvalIMBRUVICA (IBRUTINIB) — FDA approvalDec 20, 2024
- approvalCARIPRAZINE HYDROCHLORIDE: VRAYLAR (CARIPRAZINE HYDROCHLORIDE) — FDA approvalNov 22, 2024
- approvaldivalproex sodium DR: DEPAKOTE (DIVALPROEX SODIUM) — FDA approvalJan 23, 2025
- approvaldivalproex sodium DR: DEPAKOTE ER (DIVALPROEX SODIUM) — FDA approvalJan 23, 2025
- approvaldivalproex sodium DR: DEPAKOTE (DIVALPROEX SODIUM) — FDA approvalJan 23, 2025
🐶 often sniffed alongside
top 8- tagApproval168 co-mentions · 84 sources
- drugHUMIRA122 co-mentions · 61 sources
- drugadalimumab122 co-mentions · 61 sources
- drugABRILADA61 co-mentions · 61 sources
- drugYUSIMRY61 co-mentions · 61 sources
- drugAMJEVITA61 co-mentions · 61 sources
- drugSKYRIZI46 co-mentions · 23 sources
- drugrisankizumab46 co-mentions · 23 sources
comments(0)
5-min edit window · permanent after that